Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) saw an uptick in trading volume on Tuesday . 103,782 shares were traded during mid-day trading, an increase of 35% from the previous session’s volume of 77,041 shares.The stock last traded at $68.45 and had previously closed at $68.53.
Analysts Set New Price Targets
Separately, Zacks Research lowered shares of Lonza Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 22nd. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Lonza Group presently has a consensus rating of “Hold”.
View Our Latest Stock Report on Lonza Group
Lonza Group Stock Down 1.8%
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
See Also
- Five stocks we like better than Lonza Group
- Stock Average Calculator
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- What is a support level?
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
